Search clinical trials for: serotonin transporter

Total 6370 results

Eli Lilly and Company

Completed

A Study for the Treatment of Painful Diabetic Neuropathy

Diabetic Neuropathy, Painful

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Study of Duloxetine in the Treatment of Fibromyalgia

Fibromyalgia

Argentina, Australia, Brazil, Canada, Mexico, Poland, Taiwan
GE Healthcare

Completed

Dopamine Transporter Scintigraphy Imaging (DAT-Imaging) in Patients With Lewy Body Dementia

Vascular Dementia | Lewy Body Dementia | Alzheimer's | Non-DLB Dementia

Germany
National Institute of Mental Health (NIMH)

Completed

Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)

Bipolar Disorder

United States
BeerYaakov Mental Health Center
Lundbeck Israel

Completed

The Efficacy of Escitalopram for Negative Symptoms in Schizophrenia

Schizophrenia

Israel
Yu-Li Hospital

Unknown

The Monitor of Serum Prolactin Level in a 3 Months Aripiprazole Trial

Schizophrenia, Tardive Dyskinesia, Metabolic Syndrome

Taiwan
Massachusetts General Hospital
Forest Laboratories

Completed

Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)

Obsessive Compulsive Disorder

United States
Odense University Hospital
H. Lundbeck A/S; Aarhus University Hospital

Completed

Escitalopram as a Treatment for Pain in Polyneuropathy

Pain | Polyneuropathies

Denmark
University of Aarhus
The Danish Medical Research Council; Fund for Advancement of Medical Science; Max Woerzner's Research Award

Completed

PET Neuroimaging of [11C]Mirtazapine

Mental Disorders | Mood Disorders | Affective Disorders | Depressive Disorders

Denmark
Veterans Medical Research Foundation

Completed

Effect of Switch to Aripiprazole on Health and Smoking Parameters in Patients With Schizophrenia: A Pilot Study

Schizophrenia

United States
Yale University
Donaghue Medical Research Foundation

Completed

Nicotinic Receptor Augmentation of SSRI Antidepressants

Depressive Disorder

United States
Radboud University Medical Center
ZonMw: The Netherlands Organisation for Health Research and Development

Completed

Effect of Polymorphisms in the Adenosine a2a Receptor Gene and AMPD2 Gene on Adenosine-Induced Vasodilation and Reactive Hyperemia

Blood Flow in Healthy Volunteers

Netherlands
Indiana University School of Medicine

Completed

Aripiprazole Treatment of Bipolar Depression

Bipolar Depression

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating DVS-233 for Treatment of Outpatients With Major Depressive Disorder

Major Depressive Disorder
ACADIA Pharmaceuticals Inc.

Completed

Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone

Schizophrenia

United States, Brazil
Tuscaloosa Research & Education Advancement Corporation
Abbott

Completed

Divalproex ER vs. Risperidone for Bipolar Disorder With Comorbid Substance Use Disorder

Bipolar Depression | Substance Abuse

United States
Sheba Medical Center
Lundbeck Israel

Unknown

Escitalopram and Sleep Architecture in Patients With Major Depressive Disorder

Major Depressive Disorder

Israel
POZEN

Completed

The Safety Of Combo Formulation In The Treatment Of Multiple Episodes Of Acute Migraine Over 12 Months

Migraine Headaches

United States
Federal University of São Paulo

Completed

Aripiprazole in the Treatment of Post-Traumatic Stress Disorder Symptoms (AripipPTSD)

Posttraumatic Stress Disorder
Washington University School of Medicine

Completed

Comparison of Applied Behavioral Analysis (ABA) Versus ABA and Risperidone

Autistic Disorder

United States
Eli Lilly and Company

Completed

Comparison of LY686017 With a Marketed Drug in the Treatment of Social Anxiety Disorder

Social Phobia

United States
POZEN

Completed

To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migraine Headaches

Migraine Headaches

United States
POZEN

Completed

To Evaluate the Safety and Efficacy of Trexima in the Acute Treatment of Migrane Headaches

Migraine Headaches

United States
The New England Center for Headache, P.C.
Ortho-McNeil Neurologics, Inc.

Unknown

Detoxification and Treatment of Subjects With Medication Overuse Headache

Analgesic Rebound Headache

United States
National Center for Complementary and Integrative...

Completed

Herb-Opioid Interactions

Pain

United States
University Hospital Muenster

Unknown

Renal Transporters After Renal Transplantation

Kidney Transplantation | Host vs Graft Reaction

Germany
Psychiatric Hospital, Hillerod
Amager Hospital; Psychiatric Center Ballerup; Psychogeriatric Unit, CU Hospital... and other collaborators

Terminated

Treatment of Depression in the Elderly

Depression

Denmark
University of New Mexico
GlaxoSmithKline

Completed

A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department

Nausea | Vomiting

United States
University of Medicine and Dentistry of New Jersey
Bristol-Myers Squibb

Completed

Aripiprazole for the Treatment of Schizophrenia With Co-Morbid Social Anxiety

Schizophrenia | Schizoaffective Disorder | Social Anxiety Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Duloxetine in the Treatment of Stress Urinary Incontinence.

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Determine How Effective Duloxetine is in Treating Women 65 Years and Older With Symptoms of Stress Urinary Incontinence, or With a Combination of Stress Urinary Incontinence and Urge Urinary Incontinence Symptoms

Urinary Incontinence, Stress

France, Sweden, Netherlands, Spain, Germany, South Africa, Switzerland
Eli Lilly and Company

Completed

Bipolar Depression Study: Bipolar Depression Assessment Study on Treatment Response

Depression, Bipolar

United States, Puerto Rico
Eli Lilly and Company

Completed

Olanzapine Plus Carbamazepine in the Treatment of Bipolar I Mania

Bipolar Disorder

Hungary, Australia, Greece, Russian Federation
Eli Lilly and Company
Boehringer Ingelheim

Completed

Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence

Urinary Incontinence, Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety of Duloxetine in Patients With Stress Urinary Incontinence

Stress Urinary Incontinence

United States, Canada
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness and Safety of Duloxetine in Women Experiencing Urinary Leakage Due to Physical Stress and Urge.

Urinary Incontinence, Stress

United States, Canada, United Kingdom
Eli Lilly and Company

Completed

Biomechanical and Electrophysiological Effects of Duloxetine in the Treatment of Women With Urinary Stress Incontinence

Urinary Stress Incontinence

United States, Slovenia, United Kingdom
Eli Lilly and Company

Completed

Efficacy of High Dose Olanzapine for the Treatment of Schizophrenia and Schizoaffective Disorder

Schizophrenia | Schizoaffective Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine, Placebo and Pelvic Floor Muscle Training in Subjects With Stress Urinary Incontinence

Urinary Stress Incontinence

United States, Netherlands
Eli Lilly and Company

Completed

Olanzapine vs. Comparator and Placebo in the Treatment of Patients With Bipolar I Disorder

Bipolar Disorder

United States, Lithuania, Puerto Rico, Romania, Russian Federation
Eli Lilly and Company

Completed

A Comparison of Tolerability and Efficacy of Different Doses of Duloxetine for the Treatment of Major Depressive Disorder

Depressive Disorder

United States
Eli Lilly and Company
Boehringer Ingelheim

Completed

A Randomized Double Blind Study Evaluating Duloxetine in Outpatients With MDD and Pain

Depressive Disorder, Major

Belgium, Germany, France, Slovakia, Czech Republic, Finland
Eli Lilly and Company
Boehringer Ingelheim

Completed

Effectiveness of Duloxetine in the Treatment of Stress Urinary Incontinence(Uncontrolled Leakage of Urine)

Urinary Incontinence, Stress

Brazil, Canada, France, Germany, Italy, Mexico, Puerto Rico, Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

Open Label Phase III Duloxetine Study for Stress Urinary Incontinence

Urinary Incontinence Stress

United Kingdom
Eli Lilly and Company
Boehringer Ingelheim

Completed

Efficacy and Safety of Duloxetine

Urinary Stress Incontinence

United Kingdom
Eli Lilly and Company

Completed

A Study on Induced Weight Gain During Atypical Antipsychotic Treatment and Its Management With Psychoeducational Programme

Weight Gain

Italy
Eli Lilly and Company
Boehringer Ingelheim

Completed

Biomechanical Effects of Duloxetine on Bladder and Sphincter Muscle Function in Women in Pure Genuine Stress Incontinence

Urinary Stress Incontinence

United States
Eli Lilly and Company

Completed

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

Major Depressive Disorder

Spain
Eli Lilly and Company
Boehringer Ingelheim

Completed

To Evaluate the Safety in Patients Taking Duloxetine for Stress Urinary Incontinence

Stress Urinary Incontinence

United States
Indiana University School of Medicine

Terminated

Galantamine Augmentation of Escitalopram for Treatment of Depression

Depression

United States

Search clinical trials for: serotonin transporter

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Argentina

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations